We are live on
!
Find out more
CRM
Cramer Rosenthal McGlynn Portfolio holdings
AUM
$1.36B
1-Year Est. Return
31.72%
This Fund
S&P 500
This Quarter
Est. Return
-10.57%
1 Year Est. Return
+31.72%
3 Year Est. Return
+70.83%
5 Year Est. Return
+96.16%
10 Year Est. Return
+415.48%
AUM
$2.18B
AUM Growth
-$386M
(-15%)
Cap. Flow
-$83.9M
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
25.97%
Holding
106
New
11
Increased
30
Reduced
57
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LeMaitre Vascular
LMAT
|
+$20.6M |
| 2 |
Matador Resources
MTDR
|
+$16.8M |
| 3 |
QuidelOrtho
QDEL
|
+$16.2M |
| 4 |
Burlington
BURL
|
+$15.7M |
| 5 |
Lamb Weston
LW
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$30.3M |
| 2 |
Bankunited
BKU
|
+$28M |
| 3 |
G-III Apparel Group
GIII
|
+$20.4M |
| 4 |
Valmont Industries
VMI
|
+$18.9M |
| 5 |
Janus International
JBI
|
+$14.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.59% |
| 2 | Financials | 19.04% |
| 3 | Technology | 10.65% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Healthcare | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Valmont Industries
VMI
$9.44B
| $63.8M | 2.93% |
283,838
-77,049
| -21% | -$18.9M |
|
2
Envista
NVST
$4.28B
| $63.6M | 2.92% |
1,650,239
-81,107
| -5% | -$3.41M |
|
|
CHX
3
DELISTED
ChampionX
CHX
| $63.6M | 2.92% |
3,202,885
-298,072
| -9% | -$6.73M |
|
4
Kirby Corp
KEX
$7.95B
| $61.2M | 2.81% |
1,005,832
-69,260
| -6% | -$4.51M |
|
5
Clean Harbors
CLH
$16.1B
| $61M | 2.8% |
695,390
-15,848
| -2% | -$1.53M |
|
6
LKQ Corp
LKQ
$6.58B
| $59.5M | 2.73% |
1,212,492
+32,364
| +3% | +$1.59M |
|
|
7
Lamb Weston
LW
$6.82B
| $55M | 2.52% |
769,182
+188,665
| +32% | +$12.5M |
|
8
Tenable Holdings
TENB
$3.56B
| $47.6M | 2.19% |
1,049,047
+49,168
| +5% | +$2.53M |
|
9
Steven Madden
SHOO
$3.12B
| $46.5M | 2.14% |
1,444,115
-86,868
| -6% | -$3.29M |
|
10
Ashland
ASH
$3.04B
| $43.7M | 2.01% |
424,511
-37,205
| -8% | -$3.81M |
|
11
American Financial Group
AFG
$11.9B
| $43.7M | 2.01% |
315,057
-20,635
| -6% | -$2.9M |
|
12
First Interstate BancSystem
FIBK
$3.7B
| $42.8M | 1.97% |
1,123,375
-145,168
| -11% | -$5.18M |
|
|
AAT
13
American Assets Trust
AAT
$1.49B
| $42.2M | 1.94% |
1,420,368
-160,365
| -10% | -$5.37M |
|
14
Clarivate
CLVT
$1.3B
| $42.1M | 1.94% |
3,040,737
+275,881
| +10% | +$4.13M |
|
15
LPL Financial
LPLA
$26.3B
| $39.6M | 1.82% |
214,502
-1,684
| -0.8% | -$320K |
|
16
Webster Financial
WBS
$12.3B
| $39.3M | 1.81% |
933,039
+45,282
| +5% | +$2.18M |
|
17
Black Hills Corp
BKH
$5.73B
| $38.9M | 1.79% |
534,222
-49,302
| -8% | -$3.7M |
|
|
CADE
18
DELISTED
Cadence Bank
CADE
| $37.6M | 1.73% |
1,600,869
-169,176
| -10% | -$4.35M |
|
|
KAMN
19
DELISTED
Kaman Corp
KAMN
| $36.2M | 1.66% |
1,158,545
-100,913
| -8% | -$3.74M |
|
|
PXD
20
DELISTED
Pioneer Natural Resource Co.
PXD
| $36.1M | 1.66% |
161,691
-2,081
| -1% | -$528K |
|
21
NiSource
NI
$22.4B
| $32.1M | 1.47% |
1,086,835
-12,292
| -1% | -$372K |
|
22
CVB Financial
CVBF
$3.98B
| $31.5M | 1.45% |
1,270,120
-178,379
| -12% | -$4.26M |
|
23
Hancock Whitney
HWC
$6.13B
| $31.3M | 1.44% |
705,478
-153,586
| -18% | -$7.31M |
|
24
Regal Rexnord
RRX
$14.2B
| $30.5M | 1.4% |
269,084
-1,707
| -0.6% | -$217K |
|
25
SPX Corp
SPXC
$11B
| $29.9M | 1.37% |
565,025
-115,576
| -17% | -$5.58M |
|
Similar funds
AL
BFG
SFM
LWM
VC
FC
DC
PGP
Cramer Rosenthal McGlynn's Q2 2022 Portfolio in Review
As of Q2 2022, Cramer Rosenthal McGlynn held 106 positions worth $2.18B, down 15% from $2.56B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cramer Rosenthal McGlynn withdrew a net $83.9M in Q2 2022, closing 7 positions and reducing 57 holdings. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
Against the trend, Cramer Rosenthal McGlynn opened a new position in LeMaitre Vascular worth $21M.
- Cramer Rosenthal McGlynn's largest Q2 2022 buy was LeMaitre Vascular: 461,403 shares worth $21M.
- Cramer Rosenthal McGlynn added most to Lamb Weston in Q2 2022, an estimated $12.5M increase.
- Cramer Rosenthal McGlynn's biggest Q2 2022 reduction was G-III Apparel Group, cutting an estimated $20.4M.
- Cramer Rosenthal McGlynn fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $30.3M.
- Cramer Rosenthal McGlynn's ten largest holdings make up 26% of its $2.18B portfolio in Q2 2022.
- Cramer Rosenthal McGlynn opened 11 new positions and closed 7 in Q2 2022.
- Cramer Rosenthal McGlynn's portfolio value fell 15% quarter-over-quarter to $2.18B.
Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2022, filed 12 Aug 2022.